"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
NCT07014904 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-06-17
Summary
the investigators aim in this study to investigate the potential association of single gene polymorphisms of CTLA-4 (SNPs; rs: 3087243) using real-time PCR in children with primary ITP.
Conditions
- ITP - Immune Thrombocytopenia
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-20
- Primary Completion
- 2027-06-04
- Completion
- 2027-07-20
More Related Trials
-
A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02403440 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP
NCT00571467 ·Status: TERMINATED ·Phase: PHASE1
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "
NCT05585944 ·Status: UNKNOWN ·Phase: NA
-
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00504075 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)
NCT05263193 ·Status: COMPLETED
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Efficacy and Safety of IVIG-L in ITP Patients
NCT00151840 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
NCT03866577 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
NCT01571349 ·Status: COMPLETED
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
NCT00005652 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)
NCT05371743 ·Status: UNKNOWN
-
Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
NCT07059910 ·Status: NOT_YET_RECRUITING
-
Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura
NCT06601543 ·Status: NOT_YET_RECRUITING
-
Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient
NCT03222843 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
NCT01506414 ·Status: COMPLETED ·Phase: PHASE3
-
TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years
NCT04890041 ·Status: RECRUITING ·Phase: NA
-
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
NCT01510873 ·Status: COMPLETED